Warfarin Tablets Suppliers & Bulk Manufacturers
Available Forms: Oral Tablets
Available Strengths: 1 mg, 2 mg, 2.5 mg, 3 mg, 4 mg, 5 mg, 6 mg, 7.5 mg, 10 mg
Reference Brands: Coumadin(US), Jantoven: (Generic version of Coumadin)
Category:
Blood Disorder
Warfarin inhibits vitamin K epoxide reductase, reducing synthesis of clotting factors II, VII, IX, and X. This anticoagulant prevents blood clots, strokes, and deep vein thrombosis. Benefits include effective long-term anticoagulation, oral administration, and proven reduction in thromboembolic events, making it essential for managing clotting disorders.
Warfarin tablets is available in Oral Tablets
and strengths such as 1 mg, 2 mg, 2.5 mg, 3 mg, 4 mg, 5 mg, 6 mg, 7.5 mg, 10 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Warfarin tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Warfarin tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Warfarin is a tightly regulated anticoagulant in both the EU and US. In the US, it is approved by the FDA, requiring a comprehensive dossier demonstrating safety, efficacy, and manufacturing practices. In the EU, it is regulated by the EMA and approved through centralized or national procedures, ensuring quality control and pharmacovigilance. As a narrow therapeutic index drug, strict monitoring guidelines are essential. For detailed guidance on dossier preparation, regulatory pathways, and market entry strategies, visit PharmaTradz. Ensuring compliance with regional regulations is crucial for successful approval and safe, effective use of warfarin globally.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing